Causes of Morbidity and Mortality from Breast Cancer
More details
Hide details
Saint Petersburg State University, Saint Petersburg, Russia.
Eugeny Kolpak   

Saint Petersburg State University, Saint Petersburg, Russia.
Publication date: 2017-08-04
Eurasian J Anal Chem 2017;12(A Multidisciplinary Approach to science 5b):779–791
This article is directed to disclosure of influence of possible risk factors of developing of a breast cancer with application of the systematic review and meta-analysis. The data specifying that the high incidence and breast cancer mortality at women are caused by age and racial features are presented in article; reliable risk factors of development of a breast cancer are analyzed; potential factors, influence and which predictive value is discussed are revealed. Materials of article open a complex of the factors promoting decrease in risk of incidence and breast cancer mortality, pay attention to preliminary systematic diagnostics at women, indicating the reasons of wide circulation of a breast cancer.
Ferlay, J., Héry, C., Autier, P. & Sankaranarayanan, R. (2010). Global burden of breast cancer. In Breast cancer epidemiology (pp. 1-19). Springer New York.
McPherson, K., Steel, C., & Dixon, J.M (2000). Breast cancer-epidemiology, risk factors, and genetics. BMJ: British Medical Journal, 321(7261), 624.
Yancik, R., Wesley, M.N., Ries, L.A, Havlik, R.J., Edwards, B.K. & Yates, J.W. (2001). Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. Jama, 285(7), 885-892.
Nixon, A.J., Neuberg, D., Hayes, D.F., Gelman, R., Connolly, J.L., Schnitt, S. & Harris, J.R. (1994). Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. Journal of Clinical Oncology, 12(5), 888-894.
Petrelli, J.M., Calle, E.E., Rodriguez, C. & Thun, M.J. (2002). Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes and Control, 13(4), 325-332.
Protani, M., Coory, M. & Martin, J.H. (2010). Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast cancer research and treatment, 123(3), 627-635.
Dignam, J.J, Wieand, K., Johnson, K.A., Fisher, B., Xu, L. & Mamounas, E.P (2003). Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. Journal of the National Cancer Institute, 95(19), 1467-1476.
Pierce, J.P, Stefanick, M.L., Flatt, S.W, Natarajan, L., Sternfeld, B., Madlensky, L. & Parker, B.A. (2007). Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. Journal of Clinical Oncology, 25(17), 2345-2351.
Sternfeld, B., Weltzien, E., Quesenberry, C.P., Castillo, A.L, Kwan, M., Slattery, M.L. & Caan, B.J. (2009). Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiology and Prevention Biomarkers, 18(1), 87-95.
Patterson, R.E, Flatt, S.W., Saquib, N., Rock, C.L., Caan, B.J., Parker, B.A. & Hajek, R.A. (2010). Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast cancer research and treatment, 122(3), 859-865.
Hjerl, K., Andersen, E.W., Keiding, N., Mouridsen, H.T., Mortensen, P.B. & Jørgensen, T. (2003). Depression as a prognostic factor for breast cancer mortality. Psychosomatics, 44(1), 24-30.
Goodwin, JS, Zhang, D.D. & Ostir, G.V. (2004). Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. Journal of the American Geriatrics Society, 52(1), 106-111.
Freedman, D.M, Dosemeci, M. & McGlynn, K. (2002). Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occupational and Environmental Medicine, 59(4), 257-262.
Garland, F.C, Garland, C.F., Gorham, E.D. & Young, J.F. (1990). Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Preventive medicine, 19(6), 614-622.
Loomis, D.P, Savitz, D.A. & Ananth, C.V. (1994). Breast cancer mortality among female electrical workers in the United States. Journal of the National Cancer Institute, 86(12), 921-925.
Carey, L.A, Perou, C.M., Livasy, C.A, Dressler, L.G., Cowan, D., Conway, K. & Deming, S.L. (2006). Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. Jama, 295(21), 2492-2502.
Eley, J.W, Hill, H.A, Chen, V.W, Austin, D.F, Wesley, M.N., Muss, H.B. & Hunter, C.P. (1994). Racial differences in survival from breast cancer: results of the National Cancer Institute Black / White Cancer Survival Study. Jama, 272(12), 947-954.
Smigal, C., Jemal, A., Ward, E., Cokkinides, V., Smith, R., Howe, H.L. & Thun, M. (2006). Trends in breast cancer by race and ethnicity: update 2006. CA: a cancer journal for clinicians, 56(3), 168-183.
Giwa, K.T, Padilla, G., Tejero, J., Kraemer, J., Wright, K., Coscarelli, A. & Hills, D. (2004). Understanding the breast cancer experience of women: a qualitative study of African American, Asian American, Latina and Caucasian cancer survivors. Psycho-Oncology, 13(6), 408-428.
Hortobagyi, G.N., de la Garza Salazar, J., Pritchard, K., Amadori, D., Haidinger, R., Hudis, C.A. & O'shaughnessy, J.A. (2005). The global breast cancer burden: variations in epidemiology and survival. Clinical breast cancer, 6(5), 391-401.
Ford, D., Easton, D.F. & Peto, J. (1995). Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. American journal of human genetics, 57(6), 1457.
Sellers, T.A., Mink, P.J., Cerhan, J.R., Zheng, W., Anderson, K.E., Kushi, L.H. & Folsom, A.R. (1997). The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer. Annals of internal medicine, 127(11), 973-980.
Key, T.J., Verkasalo, P.K. & Banks, E. (2001). Epidemiology of breast cancer. The lancet oncology, 2(3), 133-140.
Cummings, S.R., Eckert, S., Krueger, K.A., Grady, D., Powles, T.J., Cauley, J.A. & Lippman, M.E. (1999). The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Jama, 281(23), 2189-2197.
Youlden, D.R, Cramb, S.M, Dunn, N.A., Muller, J.M, Pyke, C.M. & Baade, P.D. (2012). The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer epidemiology, 36(3), 237-248.
Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N. & Stratton. (1999). Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. Journal of the National Cancer Institute, 91(11), 943-949.
Tokuhata, G.K. (1969). Morbidity and mortality among offspring of breast cancer mothers. American journal of epidemiology, 89(2), 139-153.
Loi, S., Milne, R.L., Friedlander, M.L., McCredie, M.R., Giles, G.G., Hopper, J.L. & Phillips, K.A. (2005). Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiology and Prevention Biomarkers, 14(7), 1686-1691.
Barone, B.B., Yeh, H.C., Snyder, C.F., Peairs, K.S., Stein, K.B., Derr, R.L. & Brancati, F.L. (2008). Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. Jama, 300(23), 2754-2764.